| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/28/2004 | EP1383578A1 Single dose aromatase inhibitor for treating infertility |
| 01/28/2004 | EP1383573A2 Methods and apparatus for treating diseased tissue |
| 01/28/2004 | EP1383571A2 Microprojection array immunization patch and method |
| 01/28/2004 | EP1383543A1 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 01/28/2004 | EP1383540A2 Methods and pharmaceutical compositions for healing wounds |
| 01/28/2004 | EP1383539A1 Anticancer drug-chitosan complex forming self-aggregates and preparation method thereof |
| 01/28/2004 | EP1383532A2 Combination therapy |
| 01/28/2004 | EP1383531A2 Use of lp82 to treat hematopoietic disorders |
| 01/28/2004 | EP1383529A2 Methods of treating disorders of the eye and surrounding tissue with thymosin 4 (t 4), analogues, isoforms and other derivatives |
| 01/28/2004 | EP1383527A1 Methods and compositions for treating oral and esophageal lesions |
| 01/28/2004 | EP1383523A2 Agent for treating diabetes mellitus |
| 01/28/2004 | EP1383516A1 Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer |
| 01/28/2004 | EP1383515A1 Activation of natural killer cells by adenosine a3 receptor agonists |
| 01/28/2004 | EP1383514A1 Composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters |
| 01/28/2004 | EP1383511A2 Calcilytic compounds |
| 01/28/2004 | EP1383506A2 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7 |
| 01/28/2004 | EP1383505A2 Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease |
| 01/28/2004 | EP1383504A1 Sustained release drug delivery system containing codrugs |
| 01/28/2004 | EP1383502A2 Compounds and methods for the treatment of urogenital disorders |
| 01/28/2004 | EP1383501A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 01/28/2004 | EP1383495A1 Duloxetine for treatment of hot flashes |
| 01/28/2004 | EP1383493A1 Inhibition of pigmentation by inhibition of fatty acid synthase |
| 01/28/2004 | EP1383491A2 Synergistic combinations of retinoid receptor ligands and selected cytotoxic agents for treatment of cancer |
| 01/28/2004 | EP1383490A1 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| 01/28/2004 | EP1383486A2 Compositions containing cgmp pde inhibitors and local anestetic agents for nasal application |
| 01/28/2004 | EP1383481A1 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 01/28/2004 | EP1383474A2 Methods and compositions that affect melanogenesis (pfi-016cip/pct) |
| 01/28/2004 | EP1383465A2 Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning |
| 01/28/2004 | EP1383391A1 Mixtures of fructose and lactose as a low-calorie bulk sweetener with reduced glycemic index |
| 01/28/2004 | EP1383385A1 Use of ppar-alpha-gamma ligands or agonists to prevent the rupture of atherosclerotic plaques |
| 01/28/2004 | EP1383379A1 Restoration of cancer-suppressing functions to neoplastic cells through dna hypomethylation |
| 01/28/2004 | EP1217990B1 Cationic dosper virosomes |
| 01/28/2004 | EP1214066A4 Formation of nanometer-scale structures |
| 01/28/2004 | EP1183237B1 Novel antioxidants, preparation methods and uses |
| 01/28/2004 | EP1143946B1 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 01/28/2004 | EP0957900B1 Compositions and methods for topical application of therapeutic agents |
| 01/28/2004 | EP0906100B1 Use of 5-ht 1a? receptor antagonists for the treatment of urinary incontinence |
| 01/28/2004 | CN1471535A Tricyclic derivatives of indole with antiangiogenic activity |
| 01/28/2004 | CN1471524A Novel farnesyl protein transferase inhibitors as antitumor |
| 01/28/2004 | CN1471512A Gem-substituted ± ¢ ²3 integrin antagonists |
| 01/28/2004 | CN1471402A Compositions and methods for diagnosis and treatment of cardiovascualr disorders |
| 01/28/2004 | CN1471400A Combination therapy for the treatment of estrogen-sensitive disease |
| 01/28/2004 | CN1471397A Method for treatment of migraine |
| 01/28/2004 | CN1471395A Apomorphine derivatives and methods for their use |
| 01/28/2004 | CN1471393A Method for the treatment of neurological and neuropsychological disorders |
| 01/28/2004 | CN1471392A Method for the treatment of neurological and neuropsychological disorders |
| 01/28/2004 | CN1471391A Composition and method for treatment of hypertriglyceridemia |
| 01/28/2004 | CN1471390A Combination of fenofibrate and coenzyme Q10 for the treatment of endothelial dysfunction |
| 01/28/2004 | CN1471389A Ibuprofen solutions for capsule-filling and capsule preparations |
| 01/28/2004 | CN1135988C Use of botulinum toxin in preparing pharmaceutical composition for treating prostatic disorders |
| 01/27/2004 | US6683172 Composition for inhibiting inflammatory response comprising at least one nucleic acid molecule selected from specified sequences |
| 01/27/2004 | US6683114 Using norepinephrine reuptake inhibitors such as tomoxetine hydrochloride |
| 01/27/2004 | US6683080 Treatment of diabetes mellitus |
| 01/27/2004 | US6683076 Methods for therapeutic use of glucosylceramide synthesis inhibitors and composition thereof |
| 01/27/2004 | US6683064 First polysaccharide crosslinked to second polysaccharide, selected from hyaluronic acid, dextran, dextran sulfate, chondroitin sulfate, dermatan sulfate, keratan sulfate, heparin, heparan sulfate and alginate |
| 01/27/2004 | US6683063 Lipopolysaccharide disorders |
| 01/27/2004 | US6683062 Attaching a bioeffecting agent to a substrate with an anchor provided by a linker compound which also forms a cleavable linkage so that the drug has a sustained release; anti-thrombogenic, -imicrobial, -inflammatory agents |
| 01/27/2004 | US6683057 Suppressing g beta gamma signaling; reducing intimal hyper-plasia following vein grafting and restenosis following arterial injury |
| 01/27/2004 | US6683056 Synergistic mixture with antilipemic agent |
| 01/27/2004 | US6683053 Insulin-like growth factor agonist molecules |
| 01/27/2004 | US6683051 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor |
| 01/27/2004 | US6682902 Human extracellular matrix polypeptides; polynucleotides; expression vectors; host cells; medical diagnosis; prostate cancer; detection of metastasis |
| 01/27/2004 | US6682762 Poultry and livestock feed additive |
| 01/27/2004 | US6682734 Anti-cd20 derived from transfectoma having atcc deposit numbers 69119 and hbe 1388 respectively; depletion of peripheral blood b cells |
| 01/27/2004 | US6682520 Tissue volume reduction |
| 01/27/2004 | US6682348 Dispensing apparatus and cartridge |
| 01/27/2004 | CA2254772C Liposomal antineoplaston therapies with markedly improved antineoplastic activity |
| 01/27/2004 | CA2144094C Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract |
| 01/27/2004 | CA2123739C Formulations containing carotenoids and procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals |
| 01/27/2004 | CA2081604C Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug |
| 01/22/2004 | WO2004008147A2 Diagnosis and prevention of cancer cell invasion |
| 01/22/2004 | WO2004007770A2 Method for diagnosis of intestinal-type gastric tumors |
| 01/22/2004 | WO2004007769A1 Method of screening remedy for aids |
| 01/22/2004 | WO2004007764A2 Chromosome 3, 5 and 11 genes involved in premature canities |
| 01/22/2004 | WO2004007747A2 Assays for assembly of ebola virus nucleocapsids |
| 01/22/2004 | WO2004007734A1 Her-2/neu dna vaccine having anti-cancer activity |
| 01/22/2004 | WO2004007723A2 Genes |
| 01/22/2004 | WO2004007697A2 Methods of implanting mesenchymal stem cells for tissue repair and formation |
| 01/22/2004 | WO2004007682A2 Methods and compositions for modulating t helper (th) cell development and function |
| 01/22/2004 | WO2004007531A2 Activated checkpoint therapy and methods of use thereof |
| 01/22/2004 | WO2004007512A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 01/22/2004 | WO2004007461A1 8-hydroxy quinoline derivatives |
| 01/22/2004 | WO2004007437A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 01/22/2004 | WO2004007025A1 Combination of an allosteric alkyne inhibitor of matrix metalloproteinase-13 with a selective inhibitor of cyclooxygenase-2 that is not celecoxib or valdecoxib |
| 01/22/2004 | WO2004007024A1 Combination of an allosteric inhibitor of matrix metalloproteinase-13 with a selective inhibitor of cyclooxygenase-2 that is not celecoxib or valdecoxib |
| 01/22/2004 | WO2004007020A2 Thermotherapy method for treatment and prevention of breast cancer and cancer in other organs |
| 01/22/2004 | WO2004006956A1 Drugs for improving the prognosis of brain injury and a method of screening the same |
| 01/22/2004 | WO2004006953A2 Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells |
| 01/22/2004 | WO2004006945A1 Tablet composition containing chinese orthodox medicine extract and process for producing the same |
| 01/22/2004 | WO2004006936A1 Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy |
| 01/22/2004 | WO2004006931A2 Pharmaceutical compostions comprising an allosteric carboxylic inhibitor of matrix metalloproteinase-13 and a selective inhibitor of cyclooxygenase-2 |
| 01/22/2004 | WO2004006920A1 Topical treatment of skin diseases |
| 01/22/2004 | WO2004006911A2 Compositions intended for the treatment of peripheral neuropathies, preparation thereof and uses of same |
| 01/22/2004 | WO2004006902A1 Combination of an allosteric inhibitor or matrix metalloproteinase-13 with a selective inhibitor of cyclooxygenase-2 that is not celecoxib or valdecoxib |
| 01/22/2004 | WO2004006901A1 Gastrointestinal compositions comprising gaba derivatives |
| 01/22/2004 | WO2004006900A2 Sulphydryl compounds in combination with sulphone or sulphnamide conpounds for use in microbial inflammatory diseases |
| 01/22/2004 | WO2004006899A1 Combination of an ibat inhibitor and a metal salt for the treatment of diarrhoea |
| 01/22/2004 | WO2004006865A2 Compounds, compositions, and methods |
| 01/22/2004 | WO2004006853A2 Treatment and prophylaxis with 4-1bb-binding agents |
| 01/22/2004 | WO2004006849A2 Combinations of drugs for the treatment of neoplasms |